Lingzhi Li
-
- Cancer, Hypoxia, and Metabolism 2
- MicroRNA in disease regulation 2
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes 2
- Acute Kidney Injury Research 2
-
- Circular RNAs in diseases 3
- Biochemical and Molecular Research 2
- Chemical Synthesis and Analysis 1
-
- Chemotherapy-induced organ toxicity mitigation 2
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lingzhi Li
20 papers receiving 482 citations
Peers
Comparison fields: 5 of 93
- Cancer Research 108
- Nephrology 44
- Developmental Neuroscience 19
- Molecular Medicine 20
- Molecular Biology 262
Countries citing papers authored by Lingzhi Li
This map shows the geographic impact of Lingzhi Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingzhi Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingzhi Li more than expected).
Fields of papers citing papers by Lingzhi Li
This network shows the impact of papers produced by Lingzhi Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingzhi Li. The network helps show where Lingzhi Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lingzhi Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 4 | |
| 3 | 2023 | 22 | |
| 4 | 2023 | 19 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 76 | |
| 7 | 2021 | 1 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 17 | |
| 10 | 2020 | 10 | |
| 11 | 2020 | 1 | |
| 12 | 2019 | 60 | |
| 13 | 2019 | 37 | |
| 14 | 2018 | 6 | |
| 15 | 2018 | 56 | |
| 16 | 2018 | 36 | |
| 17 | 2017 | 2 | |
| 18 | 2016 | 8 | |
| 19 | 2013 | 50 | |
| 20 | 2006 | 81 |
About Lingzhi Li
Lingzhi Li is a scholar working on Nephrology, Cancer Research and Oncology, having authored 20 papers that have together received 491 indexed citations. Recurring topics across this work include Circular RNAs in diseases (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Biochemical and Molecular Research (2 papers), MicroRNA in disease regulation (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Acute Kidney Injury Research (2 papers), Chemotherapy-induced organ toxicity mitigation (2 papers) and Chemical Synthesis and Analysis (1 paper). The work is most often cited by research in Cancer Research (108 citations), Nephrology (44 citations) and Developmental Neuroscience (19 citations). Lingzhi Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Bor Luen Tang, Yanan Chen, Xin Wang, Huifang Liu, Liang Ma, Fan Guo, Rongshuang Huang, Ping Fu, Sibei Tao and Chitra Thakur. Their work appears in journals such as Blood, Molecular Therapy, Bioscience Reports, Genes & Cancer and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.